D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 05 02 2020
accepted: 28 04 2020
pubmed: 27 5 2020
medline: 24 11 2020
entrez: 27 5 2020
Statut: ppublish

Résumé

Aging societies comprise an increasing number of elderly gastric cancer (GC) patients. We herein attempted to determine whether D2 lymphadenectomy is beneficial for older GC patients. We retrospectively analyzed a multi-institutional dataset including 3484 patients who received surgical resection for GC. For the analysis, we selected patients aged ≥ 80 years who were clinically diagnosed with T1N + or T2-4 GC. To balance the essential variables including the type of gastrectomy and the stage of progression, propensity score matching was conducted, and we compared the background clinical factors and postoperative outcomes of the patients allocated to the D2 (n = 87) and non-D2 (n = 87) dissection groups. The D2 group had significantly longer operative times, more blood loss, and more retrieved lymph nodes (median 32 vs 24, P < 0.001) than the non-D2 group. The D2 group had a greater incidence of intra-abdominal abscesses (grade ≥ II in the Clavien-Dindo classification) than the non-D2 group (3.5% vs 0%, P = 0.040). The overall disease-specific and relapse-free survival rates of the D2 group tended to be poorer than those of the non-D2 group (hazard ratios 1.49, 1.70 and 1.14, respectively). D2 lymphadenectomy for older patients with GC conferred little benefit regarding overall survival despite an occurrence of increased complication rates.

Identifiants

pubmed: 32451713
doi: 10.1007/s00595-020-02021-7
pii: 10.1007/s00595-020-02021-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1434-1442

Auteurs

Takahiro Shinozuka (T)

Department of Surgery, Ichinomiya Municipal Hospital, Ichinomiya, Japan.
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
Department of Surgery, Komaki City Hospital, Komaki, Japan.

Mitsuro Kanda (M)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. m-kanda@med.nagoya-u.ac.jp.

Seiji Ito (S)

Department of Gastroenterological Surgery, Aichi Cancer Center, Nagoya, Japan.

Yoshinari Mochizuki (Y)

Department of Surgery, Komaki City Hospital, Komaki, Japan.

Hitoshi Teramoto (H)

Department of Surgery, Yokkaichi Municipal Hospital, Yokkaichi, Japan.

Kiyoshi Ishigure (K)

Department of Surgery, Konan Kosei Hospital, Konan, Japan.

Toshifumi Murai (T)

Department of Surgery, Ichinomiya Municipal Hospital, Ichinomiya, Japan.

Takahiro Asada (T)

Department of Surgery, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.

Akiharu Ishiyama (A)

Department of Surgery, Okazaki City Hospital, Okazaki, Japan.

Hidenobu Matsushita (H)

Department of Surgery, Tosei General Hospital, Seto, Japan.

Chie Tanaka (C)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Daisuke Kobayashi (D)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Michitaka Fujiwara (M)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Kenta Murotani (K)

Biostatistics Center, Graduate School of Medicine, Kurume University, Kurume, Japan.

Yasuhiro Kodera (Y)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH